Bornaprine
![]() | |
| Clinical data | |
|---|---|
| Trade names | Sormodren |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth (tablets) |
| ATC code | N04AA11 (WHO) |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 96% |
| Metabolism | Extensive |
| Excretion | Urine (mainly)[1] |
| Identifiers | |
| |
| CAS Number | 20448-86-6 26908-91-8 |
| PubChem (CID) | 30160 |
| ChemSpider |
28011 |
| UNII |
9M363FGA7J |
| KEGG | D07302 |
| ChEMBL | CHEMBL2104596 |
| ECHA InfoCard | 100.205.286 |
| Chemical and physical data | |
| Formula | C21H31NO2 |
| Molar mass | 329.476 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Bornaprine (brand name Sormodren) is an anticholinergic used as an antiparkinsonian agent.[2][3]
References
- ↑ "Sormodren Tabletten" (PDF) (in German). BGP Products Ges.m.b.H. Perfektastraße 84A, 1230 Wien. Retrieved 30 August 2016.
- ↑ Cantello, R.; Riccio, A.; Gilli, M.; Delsedime, M.; Scarzella, L.; Aguggia, M.; Bergamasco, B. (1986). "Bornaprine vs placebo in Parkinson disease: Double-blind controlled cross-over trial in 30 patients". Italian journal of neurological sciences. 7 (1): 139–143. doi:10.1007/BF02230432. PMID 3514543.
- ↑ Jasek, W, ed. (2007). Austria-Codex (in German) (62nd ed.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4.
This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
